Given the ability of MI-3 to increase macroH2A2 protein levels and repress self-renewal in a macroH2A2-dependent fashion, we decided to use this chemical compound to further interrogate the molecular function of macroH2A2 in GBM. The gene discussed is MACROH2A2; the disease is glioblastoma.